Cargando…

Tissue factor and its procoagulant activity on cancer‐associated thromboembolism in pancreatic cancer

Pancreatic cancer frequently involves cancer‐associated thromboembolism, which is strongly associated with poor prognosis. Tissue factor, a blood coagulation factor largely produced in cancer patients as a component of extracellular vesicles, plays a key role in the incidence of cancer‐associated th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kobayashi, Satoshi, Koizume, Shiro, Takahashi, Tomoko, Ueno, Makoto, Oishi, Ritsuko, Nagashima, Shuhei, Sano, Yusuke, Fukushima, Taito, Tezuka, Shun, Morimoto, Manabu, Nakamura, Sho, Narimatsu, Hiroto, Ruf, Wolfram, Miyagi, Yohei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8586686/ https://www.ncbi.nlm.nih.gov/pubmed/34382298 http://dx.doi.org/10.1111/cas.15106

Ejemplares similares

Authors' reply to the Letter to the Editor: Tissue factor and its procoagulant activity on cancer‐associated thromboembolism in pancreatic cancer
por: Koizume, Shiro, et al.
Publicado: (2022)

Tissue factor in cancer-associated thromboembolism: possible mechanisms and clinical applications
por: Koizume, Shiro, et al.
Publicado: (2022)

Modified FOLFIRINOX versus sequential chemotherapy (FOLFIRI/FOLFOX) as a second‐line treatment regimen for unresectable pancreatic cancer: A real‐world analysis
por: Tezuka, Shun, et al.
Publicado: (2021)

Association between time to stent dysfunction and the anti-tumour effect of systemic chemotherapy following stent placement in patients with pancreaticobiliary cancers and malignant gastric outlet obstruction: a retrospective cohort study
por: Kobayashi, Satoshi, et al.
Publicado: (2021)

Tissue Factor–Factor VII Complex As a Key Regulator of Ovarian Cancer Phenotypes
por: Koizume, Shiro, et al.
Publicado: (2015)

Lipid Droplets: A Key Cellular Organelle Associated with Cancer Cell Survival under Normoxia and Hypoxia
por: Koizume, Shiro, et al.
Publicado: (2016)

Diverse Mechanisms of Sp1-Dependent Transcriptional Regulation Potentially Involved in the Adaptive Response of Cancer Cells to Oxygen-Deficient Conditions
por: Koizume, Shiro, et al.
Publicado: (2015)

Potential Coagulation Factor-Driven Pro-Inflammatory Responses in Ovarian Cancer Tissues Associated with Insufficient O(2) and Plasma Supply
por: Koizume, Shiro, et al.
Publicado: (2017)

FOLFOX regimen after failure of fluorouracil and leucovorin plus nanoliposomal-irinotecan therapy for advanced pancreatic cancer: a retrospective observational study
por: Kobayashi, Satoshi, et al.
Publicado: (2023)

Repeated transarterial chemoembolization with epirubicin-loaded superabsorbent polymer microspheres vs. conventional transarterial chemoembolization for hepatocellular carcinoma
por: Fukushima, Taito, et al.
Publicado: (2021)

Anti-apoptotic genes are synergistically activated in OVSAYO cells cultured under conditions of serum starvation and hypoxia
por: Koizume, Shiro, et al.
Publicado: (2015)

HIF2α-Sp1 interaction mediates a deacetylation-dependent FVII-gene activation under hypoxic conditions in ovarian cancer cells
por: Koizume, Shiro, et al.
Publicado: (2012)

Tissue factor and its procoagulant activity on cancer‐associated thromboembolism in pancreatic cancer: Comment by Mackman et al.
por: Mackman, Nigel, et al.
Publicado: (2022)

Plasma procoagulant phospholipid clotting time and venous thromboembolism risk
por: Ramberg, Cathrine, et al.
Publicado: (2021)

Prognostic significance of sarcopenia as determined by bioelectrical impedance analysis in patients with advanced pancreatic cancer receiving gemcitabine plus nab-paclitaxel: A retrospective study
por: Tozuka, Yuichiro, et al.
Publicado: (2022)

A case of pancreatic mucinous cystadenocarcinoma with malignant ascites without recurrence for more than 8 years after surgery
por: Tezuka, Shun, et al.
Publicado: (2022)

Lipid starvation and hypoxia synergistically activate ICAM1 and multiple genes in an Sp1-dependent manner to promote the growth of ovarian cancer
por: Koizume, Shiro, et al.
Publicado: (2015)

Age group differences in psychological distress and leisure-time exercise/socioeconomic status during the COVID-19 pandemic: a cross-sectional analysis during 2020 to 2021 of a cohort study in Japan
por: Saito, Yoshinobu, et al.
Publicado: (2023)

Self-production of tissue factor-coagulation factor VII complex by ovarian cancer cells
por: Yokota, N, et al.
Publicado: (2009)

Nutritional Approach to Cancer Cachexia: A Proposal for Dietitians
por: Tanaka, Kotone, et al.
Publicado: (2022)

Tissue factor pathway inhibitor-2 is specifically expressed in ovarian clear cell carcinoma tissues in the nucleus, cytoplasm and extracellular matrix
por: Ota, Yukihide, et al.
Publicado: (2021)

The impact of blood product ratio and procoagulant therapy on the development of thromboembolic events in severely injured hemorrhaging trauma patients
por: Wirtz, Mathijs R., et al.
Publicado: (2020)

Incidence of Venous Thromboembolism in Multiple Myeloma Patients across Different Regimens: Role of Procoagulant Microparticles and Cytokine Release
por: Gidaro, Antonio, et al.
Publicado: (2022)

Annexin A4 Is Involved in Proliferation, Chemo-Resistance and Migration and Invasion in Ovarian Clear Cell Adenocarcinoma Cells
por: Mogami, Tae, et al.
Publicado: (2013)

Cancer cell‐derived CD69 induced under lipid and oxygen starvation promotes ovarian cancer progression through fibronectin
por: Koizume, Shiro, et al.
Publicado: (2023)

Clinical significance of procoagulant microparticles
por: Nomura, Shosaku, et al.
Publicado: (2015)

Future Patient Incidence in Hemato-Oncology: A Study Using Data from Cancer Registries in Japan
por: Narimatsu, Hiroto, et al.
Publicado: (2020)

Dynamic thromboembolic left ventricular outflow tract obstruction after aggressive procoagulant treatment in hemorrhagic shock: a case report
por: Skrypnikov, Vladimir, et al.
Publicado: (2021)

Procoagulant inhibitory properties of paclitaxel poliglumex
por: Nemunaitis, John, et al.
Publicado: (2010)

Procoagulant and Anticoagulant Factors in Childhood Hypothyroidism
por: Kilic, Nevin, et al.
Publicado: (2012)

Impact of Epicatechin on the Procoagulant Activities of Microparticles
por: Sinegre, Thomas, et al.
Publicado: (2020)

Evaluation Procoagulant Activity and Mechanism of Astragalin
por: Li, Changqin, et al.
Publicado: (2020)

Comparative Outcomes of First-Line Chemotherapy for Metastatic Pancreatic Cancer Among the Regimens Used in Japan: A Systematic Review and Network Meta-analysis
por: Takumoto, Yuki, et al.
Publicado: (2022)

Availability of Financial and Medical Resources for Screening Providers and Its Impact on Cancer Screening Uptake and Intervention Programs
por: Takahashi, Koshi, et al.
Publicado: (2022)

The procoagulant effects of fine particulate matter in vivo
por: Kilinç, Evren, et al.
Publicado: (2011)

Procoagulant activity and thrombelastography in Korean hemorrhagic fever.
por: Lee, M., et al.
Publicado: (1986)

Polyphosphate and omptins: novel bacterial procoagulant agents
por: Yun, Thomas H, et al.
Publicado: (2009)

Structural Requirements for the Procoagulant Activity of Nucleic Acids
por: Gansler, Julia, et al.
Publicado: (2012)

Procoagulant Phosphatidylserine-Exposing Platelets in vitro and in vivo
por: Reddy, Emily C., et al.
Publicado: (2020)

Procoagulant platelets: Generation, characteristics, and therapeutic target
por: Chu, Yaxin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_n8omrs44cm9h2hv1deoa1bcr21